The discussed targets below were selected to illustrate the relevance of inflammatory drivers of NFκB (via the innate or adaptive system) to proliferative and/or metabolic pathways that can significantly contribute to the growth of cancer cells. The gene discussed is NFKB1; the disease is cancer.